These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7439247)

  • 21. Effects of thyroid dysfunction on prednisolone and prednisone interconversion and disposition in the rat.
    Murata R; Haughey DB; Jusko WJ
    Drug Metab Dispos; 1990; 18(4):403-8. PubMed ID: 1976060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of thyroid function on the pharmacokinetics of gentamicin in pigs.
    Riond JL; Dix LP; Riviere JE
    Am J Vet Res; 1986 Oct; 47(10):2141-6. PubMed ID: 3777637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma triglyceride metabolism in thyroid disease.
    Nikkilä EA; Kekki M
    J Clin Invest; 1972 Aug; 51(8):2103-14. PubMed ID: 4341014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unaltered metabolism of phenytoin in thyroid disorders.
    Mølholm Hansen J; Skovsted L; Kampmann JP; Lumholtz BI; Siersbaek-Nielsen K
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):343-6. PubMed ID: 581029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid function and bone turnover.
    Bijlsma JW; Duursma SA; Roelofs JM; der Kinderen PJ
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):42-9. PubMed ID: 6688695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug pharmacokinetics in thyroid dysfunction.
    Rodighiero V
    Minerva Endocrinol; 1985; 10(2):97-113. PubMed ID: 2415808
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics of propranolol and sotalol in hyperthyroidism.
    Aro A; Anttila M; Korhonen T; Sundquist H
    Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid hormone metabolism and the source of plasma triiodothyronine in 2-week-old rats: effects of thyroid status.
    Silva JE; Matthews P
    Endocrinology; 1984 Jun; 114(6):2394-405. PubMed ID: 6723586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidermal response to change in thyroid status.
    Holt PJ; Marks R
    J Invest Dermatol; 1977 May; 68(5):299-301. PubMed ID: 870564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propylthiouracil disposition in older hypothyroid patients.
    Sitar DS; Abu-Bakare A; Gardiner RJ
    Pharmacology; 1988; 36(2):121-4. PubMed ID: 3353438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased clearance of propranolol in thyrotoxicosis.
    Feely J; Stevenson IH; Crooks J
    Ann Intern Med; 1981 Apr; 94(4 pt 1):472-4. PubMed ID: 7212504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epidermis in thyroid disease.
    Holt PJ; Lazarus J; Marks R
    Br J Dermatol; 1976 Nov; 95(5):513-8. PubMed ID: 990170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc metabolism in thyroid disease.
    Nishi Y; Kawate R; Usui T
    Postgrad Med J; 1980 Dec; 56(662):833-7. PubMed ID: 7267493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of prolonged hyper- and hypothyroid states on the noradrenaline content of rat tissues and on the accumulation and efflux rates of tritiated noradrenaline.
    Tu T; Nash CW
    Can J Physiol Pharmacol; 1975 Feb; 53(1):74-80. PubMed ID: 1139452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Adiponectin Levels and Changes in Glucose Metabolism before and after Treatment for Thyroid Dysfunction.
    Ozdemir D; Dagdelen S; Usman A
    Intern Med; 2015; 54(15):1849-57. PubMed ID: 26234224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose transporter 2 concentrations in hyper- and hypothyroid rat livers.
    Mokuno T; Uchimura K; Hayashi R; Hayakawa N; Makino M; Nagata M; Kakizawa H; Sawai Y; Kotake M; Oda N; Nakai A; Nagasaka A; Itoh M
    J Endocrinol; 1999 Feb; 160(2):285-9. PubMed ID: 9924198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlation between the free thyroxine index and intestinal absorption of radiocalcium in thyroid diseases].
    Gennari C; Vattimo A; Nardi P; Nuti R; Picchi M; Pepi F
    Boll Soc Ital Biol Sper; 1976 May; 52(9):642-4. PubMed ID: 949453
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.
    O'Connor P; Feely J
    Clin Pharmacokinet; 1987 Dec; 13(6):345-64. PubMed ID: 3325214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing.
    Wells PG; Feely J; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1983 May; 33(5):603-8. PubMed ID: 6839632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.